|
This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA’s strategy and vision are centered around ensuring health needs for every citizen through early detection of diseases.
To Read More about our joint venture please read the BusinessWire Article
|
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...
READ MOREHigh-Efficiency Collection and Release Of Oral DNA Samples...
"The full release capacity functionality allows for adequate sample capture needed for DNA sample collection and processing." Mawi DNA Technologies, a medical device company fo...
READ MOREMeet The Mawi DNA Team We’ll be exhibiting at Booth…...
JOIN US AT ASHG | Nov 1-5, 2023 | Walter E. Washington Convention Center| Washington, D.C Mawi DNA Technologies improves the biological sample collection process with innovative technologies. Our ...
READ MORE
